A Troubling Trend: Why Breast Cancer Is Rising in Young Women and What We Need to Do About It

According to the American Cancer Society, cancer incidence rates in women under 50 are now 82% higher than in their male counterparts, which represents a 51% increase compared with 2002 data.¹ Breast cancer is the primary driver of this disparity, and Rani Bansal, MD, a breast oncologist at Duke University Cancer Center Breast Clinic, says the trend reflects a real biological change, not simply better detection.

What Is Driving the Increase?

Bansal states that causes appear to be multifactorial, and that the rise is largely confined to hormone receptor–positive (ER-positive) breast cancer. Shifting reproductive patterns offer one explanation: compared with prior generations, women today are having children later, having fewer of them, and breastfeeding less. These factors are all associated with changes in estrogen exposure and elevated breast cancer risk.

Environmental contributors may also be at work. Bansal points to growing research on endocrine-disrupting chemicals, which are compounds that may interfere with hormonal pathways and contribute to the surge in estrogen-driven cancers. She mentioned the availability of “interesting data from women born in the 1950s vs in the 1990s and how their risk is different based off when they are born.” These differing risk profiles, she says, make her think that there are likely multiple environmental and different generational factors that, over time, are shaping cancer biology in ways researchers are only beginning to understand.

Other lifestyle factors such as obesity, reduced physical activity, alcohol use, and smoking are also implicated in this increase.²

Why This Matters

Not all young women are equally affected. African American women face disproportionate rates of triple-negative breast cancer (TNBC), which is a more aggressive subtype that lacks the hormonal targets used to guide many standard therapies. "For my patients who are African American, we do tend to see higher rates of triple-negative breast cancer," Bansal explains. "And that, of course, affects how we approach treatment." Research shows that Black women are disproportionately more likely to be diagnosed with TNBC and that they face worse clinical outcomes.³

For younger women broadly, breast cancer tends to present at a more advanced stage, often because neither patient nor clinician considers it a serious possibility. This in turn also leads to worse clinical outcomes. Bansal has seen this firsthand: "Some patients will notice changes in their breast, bring it up to a provider, and get dismissed—'Oh, you're too young to have breast cancer.' I always tell my patients: advocate for yourself."

The Screening Policy Debate

The data on rising incidence have already reshaped policy. In April 2024, the US Preventive Services Task Force (USPSTF) updated its recommendation to advise biennial screening mammography beginning at age 40, lowering the threshold from age 50.⁴ Task Force Chair Wanda Nicholson, MD, MPH, MBA, noted that “by starting to screen all women at age 40, [USPSTF] can save nearly 20% more lives from breast cancer overall. This new approach has even greater potential benefit for Black women, who are much more likely to die of breast cancer.”⁵

But for women under 40, age-based screening still falls short. Bansal advocates for a risk-based approach starting at 25 by assessing family history, genetic factors like BRCA mutations, prior radiation exposure, and breast density to guide individualized screening decisions. This model recently gained support from the WISDOM trial, published in JAMA in December 2025, which found that risk-stratified screening detected cancer as effectively as annual mammography and was actually preferred by patients.⁶

"A risk-based approach is needed," Bansal says. "There are many factors that can increase a patient's lifetime risk, and a formal assessment at 25 could really help guide whether they need earlier imaging or enrollment in a high-risk clinic."

References

1. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45. doi:10.3322/caac.21871
2. Rantala J, Seppä K, Eriksson J, et al. Incidence trends of early-onset breast cancer by lifestyle risk factors. BMC Cancer. 2025;25(1):326. doi:10.1186/s12885-025-13730-y
3. Dietze EC, Sistrunk C, Miranda-Carboni G, O'Regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015;15(4):248-254. doi:10.1038/nrc3896
4. US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918-1930. doi:10.1001/jama.2024.5534
5. Task force issues final recommendation statement on screening for breast cancer. News release. US Preventive Services Task Force. April 30, 2024. Accessed May 5, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breast-cancer-screening-final-rec-bulletin.pdf
6. Goodman S. WISDOM 1.0 study results: personalized breast cancer screening is safe and smarter. WISDOM Study. December 13, 2025. Accessed May 5, 2026. https://www.thewisdomstudy.org/wisdom-1-0-study-results-personalized-breast-cancer-screening-is-safe-and-smarter/